1. Home
  2. TENX vs SIDU Comparison

TENX vs SIDU Comparison

Compare TENX & SIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.78

Market Cap

317.8M

Sector

Health Care

ML Signal

N/A

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$2.34

Market Cap

243.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
SIDU
Founded
1967
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
243.4M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
TENX
SIDU
Price
$1.78
$2.34
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
7.9M
5.5M
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
66.94
EPS
N/A
N/A
Revenue
N/A
$3,383,878.00
Revenue This Year
N/A
$171.29
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.63
52 Week High
$19.40
$6.79

Technical Indicators

Market Signals
Indicator
TENX
SIDU
Relative Strength Index (RSI) 19.03 49.16
Support Level $1.31 $1.73
Resistance Level $16.39 $2.67
Average True Range (ATR) 0.55 0.22
MACD -0.78 0.06
Stochastic Oscillator 3.48 63.02

Price Performance

Historical Comparison
TENX
SIDU

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About SIDU Sidus Space Inc.

Sidus Space Inc is a space and defense technology company with core capabilities that include dual use satellite manufacturing & technology integration, AI products and services, space and defense hardware components and space-based data solutions. The company generates revenue through a combination of: Satellite platform sales and customization, Payload hosting and mission services, Engineering and systems integration services, and Space and defense hardware manufacturing. The firm supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers. The firm generates revenue principally from satellite platform and payload hosting contracts, manufacturing and engineering services, mission operations, and sales of proprietary hardware products.

Share on Social Networks: